Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
about
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Renin angiotensin system in liver diseases: Friend or foe?Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
P2860
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Renin-Angiotensin System Inhib ...... nalcoholic Fatty Liver Disease
@ast
Renin-Angiotensin System Inhib ...... nalcoholic Fatty Liver Disease
@en
type
label
Renin-Angiotensin System Inhib ...... nalcoholic Fatty Liver Disease
@ast
Renin-Angiotensin System Inhib ...... nalcoholic Fatty Liver Disease
@en
prefLabel
Renin-Angiotensin System Inhib ...... nalcoholic Fatty Liver Disease
@ast
Renin-Angiotensin System Inhib ...... nalcoholic Fatty Liver Disease
@en
P2093
P2860
P1433
P1476
Renin-Angiotensin System Inhib ...... nalcoholic Fatty Liver Disease
@en
P2093
Anna Ludovica Fracanzani
Antonio Craxi
Elisabetta Bugianesi
Paola Dongiovanni
Salvatore Petta
Serena Pelusi
Silvia Fargion
Vittorio Borroni
P2860
P304
P356
10.1371/JOURNAL.PONE.0163069
P407
P577
2016-09-20T00:00:00Z